Events
The EMJ review spotlights cutting-edge research updates on a Phase II therapeutic trial in Hodgkin lymphoma, clonal haematopoiesis following HCT in children, and the association between CD19 expression and treatment response in large B cell lymphoma. EMJ also features several expert interviews with committee members, presenters, and award winners from the 51st Annual Meeting of the EBMT.